Therapeutic Effects of Boswellia in Different Diseases: A Systematic Review on Human Studies
-
Zahra Salehi
,
Ali Tavakoli
,
Mozhgan Moghtaderi
,
Reza Abbasizadeh
,
Hossein Molavi Vardanjani
,
Seyed Hesamedin Nabavizadeh
,
Saeed Hosseini Teshnizi
Abstract
Boswellia, has been utilized for centuries in various cultures for its potential health benefits. It is known for its anti-inflammatory, antioxidant and immune-stimulating properties. Despite its historical use, scientific evidence regarding its efficacy and safety remains limited. This systematic review aims to evaluate the effectiveness of Boswellia in treating various diseases by analyzing randomized controlled trials (RCTs) from the MEDLINE database from 2001 to the first half of 2025. Data from RCTs involving human subjects were collected, focusing on the effects of Boswellia versus placebo. Key factors included age, type of disease, dosage, and duration of treatment. Outcomes assessed included efficacy and any adverse effects associated with Boswellia use. These studies included a total of 3274 individuals, comprising 1651 cases and 1623 controls, with ages ranging from 15 to 85 years. Of the 49 selected research studies: 12 studies focused on patients with osteoarthritis, 8 studies investigated gastrointestinal diseases, 8 studies examined neurological diseases, 5 studies addressed cutaneous reactions, 5 studies looked at cancer, 3 studies on diabetes mellitus, 2 studies on oral lesions and 2 on joint pain. Labor pain, asthma, ankle sprain, and obesity each had one study dedicated to them. The majority of studies (91.8%) reported better treatment outcomes of various diseases. However, four studies specifically focused on Crohn’s disease, burn wounds, cancer-related fatigue and diabetes mellitus, showing no better outcomes. Ten studies did not consider any adverse effects, 19 studies observed no adverse reactions and the remaining studies noted minor gastrointestinal or skin manifestations with Boswellia. The review highlighted that Boswellia could serve as a complementary treatment for patients suffering from the various diseases studied. Current evidence suggests that Boswellia is generally well-tolerated. There is a need for additional investigations into its efficacy in various diseases through studies with a large number of participants.
Vuddanda PR, Singh S, Velaga S. Boswellic acid– medicinal use of an ancient herbal remedy. J Herb Med 2016;4:163-170.
Ernst E. Frankincense: systematic review. BMJ 2008;337:a2813.
JS P, Marapur S, Kadam D, Kamalapur M. Pharmaceutical and medicinal applications of Olibanum gum and its constituents: A review. J Pharm Res 2010;3:587-589.
Weeks A, Daly DC, Simpson BB. The phylogenetic history and biogeography of the frankincense and myrrh family (Burseraceae) based on nuclear and chloroplast sequence data. Mol Phylogenet Evol 2005;1:85-101.
Siemoneit U, Koeberle A, Rossi A, Dehm F, Verhoff M, et al. Inhibition of microsomal prostaglandin E2synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. Br J Pharmacol 2011; 1:147-162.
Koeberle A, Henkel A, Verhoff M, Tausch L, König S, et al. Triterpene Acids from Frankincense and Semi-Synthetic Derivatives That Inhibit 5-Lipoxygenase and Cathepsin G. Molecules 2018;2:506.
Umar S, Umar K, Sarwar AHMG, Khan A, Ahmad N, et al. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine 2014;6:847-856.
Langhorst J, Wulfert H, Lauche R, Klose P, Cramer H, et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. JCC 2015;1:86-106.
Trivedi VL, Soni R, Dhyani P, Sati P, Tejada S, et al. Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent. Front pharmacol 2023;14:1187181.
Takahashi M, Sung B, Shen Y, Hur K, Link A, et al. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis 2012;12:2441-2449.
Mahdian D, Abbaszadeh-Goudarzi K, Raoofi A, Dadashizadeh G, Abroudi M, et al. Effect of Boswellia species on the metabolic syndrome: A review. IJMS 2020;12:1374-1381.
Rajabian A, Sadeghnia H, Fanoudi S, Hosseini A. Genus Boswellia as a new candidate for neurodegenerative disorders. Iran J Basic Med Sci 2020;3:277-286.
Higgins JP, Savović J, Page MJ, Elbers RG, Sterne JA. Assessing risk of bias in a randomized trial. Cochrane Handbook for Systematic Reviews of Interventions. 1st ed. 2019. Available from: https://doi.org/10.1002/9781119536604
Higgins J, Thomas J, Chandler J, Cumpston M, Li T, et al. Cochrane handbook for systematic reviews of interventions version 6.5. 2024. Available from www.cochrane.org/handbook.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;21;7:e1000097.
Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial. Phytomedicine 2003;1:3-7.
Sontakke S, Thawani V, Pimpalkhute S, Kabra P, Babhulkar S, et al. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian J Pharmacol 2007;1:27‐29.
Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee. Arthritis Res Ther 2008;4.
Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, et al. Comparative efficacy and tolerability of 5-loxinspi® and aflapinspi® against osteoarthritis of the knee: A double blind, randomized, placebo controlled clinical study. IJMS 2010;6:366-377.
Gupta P, Samarakoon S, Chandola H, Ravishankar B. Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis). AYU 2011;4:478-482.
Vishal AA, Mishra A, Raychaudhuri SP. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of Aflapin® in subjects with osteoarthritis of knee. IJMS 2011;7:615-622.
Notarnicola A, Maccagnano G, Moretti L, Pesce V, Tafuri S, et al. Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial. Int J Immunopathol Pharmacol 2016; 1:140-146.
Ricci M, Micheloni GM, Berti M, Perusi F, Sambugaro E, et al. Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis. Musculoskelet Surg 2017;1:45-49.
Majeed M, Majeed S, Narayanan NK, Nagabhushanam K. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res 2019;5:1457-1468.
Razavi SZE, Karimi M, Kamalinejad M. The efficacy of topical oliban oil (Boswellia Carterii B.) in relieving the symptoms of knee osteoarthritis. JPMRE 2019;1:7-13.
Kulkarni PD, Damle ND, Singh S, Yadav KS, Ghante MR, et al. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee. DMPT 2020;2.
Mohsenzadeh A, Karimifar M, Soltani R, Hajhashemi V. Evaluation of the effectiveness of topical oily solution containing frankincense extract in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial. BMC Res Notes 2023;1.
Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapy of active Crohn's disease with Boswellia serrata extract H 15. Z fur Phytother 2001;2:69‐75.
Gupta I, Parihar A, Malhotra P, Gupta S, Lüdtke R, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 2001;5:391‐395.
Madisch A, Miehlke S, Eichele O, Mrwa J, Bethke B, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis 2007;12:1445‐1451.
Holtmeier W, Zeuzem S, Preiss J, Kruis W, Böhm S, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy. Inflamm Bowel Dis 2011;2:573-582.
Pellegrini L, Milano E, Franceschi F, Belcaro G, Gizzi G, et al. Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract. Eur Rev Med Pharmacol Sci 2016;12.
Belcaro G, Gizzi G, Pellegrini L, Corsi M, Dugall M, et al. Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome. Eur Rev Med Pharmacol Sci 2017;9:2249-2254.
Riva A, Giacomelli L, Totogni S, Franceschi F, Eggenhoffner R, et al. Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: A randomized clinical study. Minerva Gastroenterol 2019;651:30-35.
Giacosa A, Riva A, Petrangolini G, Allegrini P, Fazia T, et al. Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects. Nutrients 2022;9:1858.
Kirste S, Treier M, Wehrle SJ, Becker G, Abdel-Tawab M, et al. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer 2011; 16:3788‐3795.
Moein P, Abbasi Fard S, Asnaashari A, Baratian H, Barekatain M, et al. The effect of Boswellia Serrata on neurorecovery following diffuse axonal injury. Brain Inj 2013;12:1454‐1460.
Majdinasab N, Siahpush A, Mousavinejad SK, Malayeri A, Sajedi SA, et al. Effect of Boswellia serrata on cognitive impairment in multiple sclerosis patients. J Herb Med 2016;3:119-127.
Baram SM, Karima S, Shateri S, Tafakhori A, Fotouhi A, et al. Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial. Inflammopharmacology 2019;6:1101‐1112.
Rezakhani S, Sedighi B, Pardakhty A, Shafiee K. Effects of boswellia serrata on improvement of memory impairment in patients with mild cognitive impairment: a double-blind, randomized, placebo-controlled study. JKMU 2020; 4:348‐355.
Karimi M, Rohani S, Akbari MG, Kargozar E, Zargaran A, et al. The efficacy of boswellia carterii oleogel in pain relief and functional improvement among patients with carpal tunnel syndrome: a triple-blind randomized, controlled trial. Shiraz E Med J 2021;9.
Meshkat S, Mahmoodi Baram S, Rajaei S, Mohammadian F, Kouhestani E, et al. Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injury. Brain Inj 2022;4:553-559.
Karima S, Aghamollaii V, Mahmoodi Baram S, Balenci L, Lanctôt KL, et al. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease. JAD 2023;1:359-370.
Pedretti A, Capezzera R, Zane C, Facchinetti E, Calzavara-Pinton P. Effects of topical boswellic acid on photo and age-damaged skin: clinical, biophysical, and echographic evaluations in a double-blind, randomized, split-face study. Planta Med 2010;6:555‐560.
Togni S, Maramaldi G, Di Pierro F, Biondi M. A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis. Clin Cosmet Investig Dermatol 2014;7:321‐327.
Togni S, Maramaldi G, Bonetta A, Giacomelli L, Di Pierro F. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Eur Rev Med Pharmacol Sci 2015;8.
Faraji A, Aghdaki M, Hessami K, Hosseinkhani A, Roozmeh S, et al. Episiotomy wound healing by Commiphora myrrha (Nees) Engl. and Boswellia carteri Birdw. in primiparous women: a randomized controlled trial. J Ethnopharmacol 2021;264:113396.
Badr P, Afsharypuor S, Tohidinik HR, Mohammadi AA, Daneshamouz S. Burn Wound Healing Effect of a Sterilized Traditional Formulation of Boswellia carteri vs. Silver Sulfadiazine Cream 1% in Patients Presenting Second-degree Burn Wounds: a Randomized, Double-blind Clinical Trial. IJMS 2023;2:137‐145.
Pasta V, Gullo G, Giuliani A, Harrath A, Alwasel S, et al. An association of boswellia, betaine and myo-inositol (Eumastós) in the treatment of mammographic breast density. A randomized, double-blind study. Eur Rev Med Pharmacol Sci 2015;22:4419-4426.
Pasta V, Dinicola S, Giuliani A, Harrath A, Alwasel S, et al. A randomized trial of Boswellia in association with betaine and myo-inositol in the management of breast fibroadenomas. Eur Rev Med Pharmacol Sci 2016;9.
Pasta V, Dinicola S, Giuliani A, Harrath AH, Alwasel SH, et al. A randomized pilot study of inositol in association with betaine and boswellia in the management of mastalgia and benign breast lump in premenopausal women. Breast Cancer: Basic Clin Res 2016;10:37‐43.
Reis D, Throne T, Keller J, Koffel C, Chen T, et al.Young-mccaughan s. cancer-related fatigue: a pilot study evaluating the effect of frankincense essential oil in patients with cancer receiving chemotherapy. Cancer Nurs 2023;3:207-216.
Valente IVB, Garcia D, Abbott A, Spruill L, Siegel J, et al. The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer. Breast Cancer Res Treat 2024;3:521-530.
Khosravi Samani M, Mahmoodian H, Moghadamnia AA, Poorsattar Bejeh Mir A, Chitsazan M. The effect of Frankincense in the treatment of moderate plaque-induced gingivitis: a double blinded randomized clinical trial. Daru J Pharm Sci 2011;4:288‐294.
Ahangarpour A, Heidari H, Fatemeh RAA, Pakmehr M, Shahbazian H, et al. Effect of Boswellia serrata supplementation on blood lipid, hepatic enzymes and fructosamine levels in type2 diabetic patients. J Diabetes Metab Disord 2014;13:1-5.
Azadmehr A, Ziaee A, Ghanei L, Huseini HF, Hajiaghaee R, et al. A randomized clinical trial study: anti-oxidant, anti-hyperglycemic and anti-hyperlipidemic effects of olibanum gum in type 2 diabetic patients. IJPR 2014;3:1003‐1010.
Ferrara T, De Vincentiis G, Di Pierro F. Functional study on Boswellia phytosome as complementary intervention in asthmatic patients. Eur Rev Med Pharmacol Sci 2015;19:3757-3762.
Franceschi F, Togni S, Belcaro G, Dugall M, Luzzi R, et al. A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players. Eur Rev Med Pharmacol Sci 2016;19:4156-4161.
Fatima S, Ahmad T, Shahid M, Sofi G. Comparative study of kundur (Boswellia serrata) and tareeq (diaphoresis) in the management of samne mufrit (obesity): a randomised clinical trial. Int J Health Sci Res 2017;7:186-196.
Feragalli B, Ippolito E, Dugall M, Cacchio M, Belcaro G, et al. Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma-a registry study. Eur Rev Med Pharmacol Sci 2017;21:20.
Esmaelzadeh-Saeieh S, Rahimzadeh M, Khosravi-Dehaghi N, Torkashvand S. The effects of inhalation aromatherapy with Boswellia carterii essential oil on the intensity of labor pain among nulliparous women. NMS 2018;2:45-49.
Mehrzadi S, Tavakolifar B, Huseini HF, Mosavat SH, Heydari M. The Effects of Boswellia serrata gum resin on the blood glucose and lipid profile of diabetic patients: a double-blind randomized placebo-controlled clinical trial. JEBIM 2018;23:2515690X18772728.
Rad MZ, Taherian H. Effect of mouthwash with Boswellia extract on the prevention of dental plaque formation in patients under mechanical ventilation. NMS 2020;2:77-82.
Pérez-Piñero S, Muñoz-Carrillo JC, Victoria-Montesinos D, García-Muñoz AM, Andreu-Caravaca L, et al. Efficacy of Boswellia serrata extract and/or an omega-3-based product for improving pain and function in people older than 40 years with persistent knee pain: a randomized double-blind controlled clinical trial. Nutrients 2023;17:3848.
Yao Q, Wu X, Tao C, Gong W, Chen M, et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct 2023;1:56.
Quicke J, Conaghan P, Corp N, Peat G. Osteoarthritis year in review 2021: epidemiology & therapy. Osteoarthr Cartil 2022;2:196-206.
Gibbs AJ, Gray B, Wallis JA, Taylor NF, Kemp JL, et al. Recommendations for the management of hip and knee osteoarthritis: a systematic review of clinical practice guidelines. Osteoarthr Cartil 2023;10:1280-1292.
Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res 2018;1:26-42.
Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;9573:1641-1657.
Gong Y, Jiang X, Yang S, Huang Y, Hong J, et al. The biological activity of 3-O-acetyl-11-keto-β-boswellic acid in nervous system diseases. Neuromolecular Med 2022;4:374-384.
Jalili C, Salahshoor MR, Moradi S, Pourmotabbed A, Motaghi M. The therapeutic effect of the aqueous extract of boswellia serrata on the learning deficit in kindled rats. Int J Prev Med 2014;5:563.
Tsai Y-C, Chang H-H, Chou S-C, Chu TW, Hsu Y-J, et al. Evaluation of the anti-atopic dermatitis effects of α-boswellic acid on Tnf-α/Ifn-γ-Stimulated HaCat Cells and DNCB-Induced BALB/c Mice. Int J Mol Sci 2022; 17:9863.
Mostafavi A, Saidi MS, Moghtaderi M. Three-dimensional simulation of circulating tumor cells magnetic isolation using a viscoelastic-based ferrofluid solution. J Magn Magn Mater 2025;619:172847.
Kavitha J, Rosario JF, Chandran J, Anbu P. Hypoglycemic and other related effects of Boswellia glabra in alloxan-induced diabetic rats. IJPP 2007;1:29-39.
Shakir Abed Almjalawi B, Alhamed TA, Alhesnawi ASM. Antibacterial activity of boswellia carterii aqueous extract and its effect on phagocytosis in vitro. Arch Razi Inst 2022;2:545-552.
Liu Z, Liu X, Sang L, Liu H, Xu Q, et al. Boswellic acid attenuates asthma phenotypes by downregulation of GATA3 via pSTAT6 inhibition in a murine model of asthma. IJCEP 2015;1:236.
Prabhavathi K, Chandra US, Soanker R, Rani PU. A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model. Indian J Pharmacol 2014;5:475-459.
| Issue | Vol 10, No 4, 2025 -In Press- | |
| Section | Review Article(s) | |
| Keywords | ||
| Boswellia Clinical trial Frankincense Systematic review Adverse effect Therapeutic effect | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
